AH
ACAD icon

Andreas Halvorsen’s Acadia Pharmaceuticals ACAD Stock Holding History

Andreas Halvorsen’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,956,266
Closed -$93.9M – 58
2014
Q4 		$93.9M Sell
2,956,266
-1,368,624
-32% -$38.8M 0.43% 47
2014
Q3 		$107M Sell
4,324,890
-432,988
-9% -$10.1M 0.43% 47
2014
Q2 		$107M Buy
4,757,878
+1,159,471
+32% +$24.2M 0.47% 41
2014
Q1 		$87.5M Buy
3,598,407
+967,762
+37% +$24.5M 0.37% 48
2013
Q4 		$65.7M Buy
+2,630,645
New +$62.1M 0.31% 52

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Andreas Halvorsen's ACAD Position: Q1 2015 in Review

Andreas Halvorsen sold out of Acadia Pharmaceuticals (ACAD) in Q1 2015, closing a stake of 2,956,266 shares — an estimated $93.9M sold.

Andreas Halvorsen first reported a position in ACAD in Q4 2013 and held it in 5 quarters. The position peaked at $107M in Q2 2014. 193 funds tracked by Wall St. Rank hold ACAD as of Q1 2015.

  • Andreas Halvorsen reported no remaining Acadia Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Andreas Halvorsen sold 2,956,266 Acadia Pharmaceuticals shares in Q1 2015, an estimated $93.9M.
  • Andreas Halvorsen first reported a position in Acadia Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • Andreas Halvorsen's Acadia Pharmaceuticals position peaked at $107M in Q2 2014.
  • 193 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2015.

Based on Viking Global Investors's 13F filing for Q1 2015, filed 15 May 2015.